Pseudomonas aeruginosa MRSN20176: clinical isolate... - BioSample

Pseudomonas aeruginosa MRSN20176: clinical isolate carrying the blaVIM-11 gene

Identifiers: BioSample: SAMN03316892; Sample name: MRSN20176

Organism: Pseudomonas aeruginosa
cellular organisms; Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas; Pseudomonas aeruginosa group

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

strain	MRSN 20176
collected by	MRSN
collection date	2013-12-29
geographic location	Afghanistan
host	Homo sapiens
host disease	missing
isolation source	Surveillance swab
latitude and longitude	missing

BioProject: PRJNA273956 Pseudomonas
Retrieve all samples from this project

Submission: Walter Reed Army Institute of Research, Erik Snesrud; 2015-01-29

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Testing standard
amikacin	resistant	>	32	mg/L	MIC	Microscan	Siemens	CLSI
aztreonam	resistant	>	16	mg/L	MIC	Microscan	Siemens	CLSI
ceftazidime	resistant	>	16	mg/L	MIC	Microscan	Siemens	CLSI
ciprofloxacin	resistant	>	2	mg/L	MIC	Microscan	Siemens	CLSI
gentamicin	resistant	>	8	mg/L	MIC	Microscan	Siemens	CLSI
imipenem	resistant	>	8	mg/L	MIC	Microscan	Siemens	CLSI
levofloxacin	resistant	>	4	mg/L	MIC	Microscan	Siemens	CLSI
piperacillin-tazobactam	resistant	>	64/4	mg/L	MIC	Microscan	Siemens	CLSI
tobramycin	resistant	>	8	mg/L	MIC	Microscan	Siemens	CLSI
amikacin	resistant	>	32	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
aztreonam	resistant	>	16	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
ceftazidime	resistant	>	16	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
ceftriaxone	resistant	>	32	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
ciprofloxacin	resistant	>	2	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
gentamicin	resistant	>	8	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
imipenem	resistant	>	8	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
levofloxacin	resistant	>	4	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
piperacillin-tazobactam	resistant	>	64/4	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
tetracycline	resistant	>	8	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
tobramycin	resistant	>	8	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
trimethoprim-sulfamethoxazole	resistant	>	2/38	mg/L	MIC	Phoenix	Becton Dickinson	CLSI
amikacin	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	CLSI
ampicillin-sulbactam	resistant	>=	32/16	mg/L	MIC	Vitek	Biomérieux	CLSI
ampicillin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	CLSI
cefazolin	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	CLSI
ceftriaxone	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	CLSI
ciprofloxacin	resistant	>=	4	mg/L	MIC	Vitek	Biomérieux	CLSI
gentamicin	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	CLSI
imipenem	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	CLSI
meropenem	susceptible	==	4	mg/L	MIC	Vitek	Biomérieux	CLSI
moxifloxacin	resistant	>=	8	mg/L	MIC	Vitek	Biomérieux	CLSI
nitrofurantoin	resistant	>=	512	mg/L	MIC	Vitek	Biomérieux	CLSI
tigecycline	resistant	>=	8	mg/L	MIC	Vitek	Biomérieux	CLSI
tobramycin	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	CLSI
trimethoprim-sulfamethoxazole	resistant	>=	16/304	mg/L	MIC	Vitek	Biomérieux	CLSI

Accession:: SAMN03316892
ID:: 3316892

BioProject Nucleotide

BioSample

National Center for Biotechnology Information

Result Filters

Send to:

Links from Nucleotide

Pseudomonas aeruginosa MRSN20176: clinical isolate carrying the blaVIM-11 gene

Supplemental Content

Related information

Recent activity